Clinical Trial Update: Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for lapatinib in metastatic breast cancer resistant to hormone therapy, with the study terminated and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Gary Schwartz | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-27